{
    "nctId": "NCT05591456",
    "briefTitle": "Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer Patients",
    "officialTitle": "Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Radiotherapy",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "detection of breast shrinkage",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* histological diagnosis of breast adenocarcinoma\n* prior modified radical mastectomy\n* negative resection margins (3 mm)\n* pathological stage pT1-pT2, N0-2 (AJCC, 2017)\n* no macroscopic evidence of distant metastases at diagnosis\n* Age 18-80 years\n* Normal hematological and biochemical laboratory tests\n* Written informed consent was obtained from all patients\n\nExclusion Criteria:\n\n* locally advanced disease pT3-pT4, N3\n* positive surgical margins\n* prior thoracic radiation\n* synchronous second primary tumor\n* distant metastases\n* pregnancy\n* presence of a concomitant psychiatric disorder precluding an aware informed consent.\n* age \\>80 years",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}